nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—CASP9—amyotrophic lateral sclerosis	0.772	1	CbGaD
Hydroxocobalamin—Cyanocobalamin—CASP9—amyotrophic lateral sclerosis	0.00708	1	CrCbGaD
Hydroxocobalamin—MMAA—hindbrain—amyotrophic lateral sclerosis	0.0046	0.091	CbGeAlD
Hydroxocobalamin—Thrombosis—Riluzole—amyotrophic lateral sclerosis	0.00278	0.0527	CcSEcCtD
Hydroxocobalamin—Lung disorder—Riluzole—amyotrophic lateral sclerosis	0.00278	0.0527	CcSEcCtD
Hydroxocobalamin—MMAA—brainstem—amyotrophic lateral sclerosis	0.00264	0.0521	CbGeAlD
Hydroxocobalamin—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.00257	0.0487	CcSEcCtD
Hydroxocobalamin—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.00218	0.0413	CcSEcCtD
Hydroxocobalamin—MMACHC—nervous system—amyotrophic lateral sclerosis	0.00211	0.0417	CbGeAlD
Hydroxocobalamin—MMACHC—central nervous system—amyotrophic lateral sclerosis	0.00203	0.0401	CbGeAlD
Hydroxocobalamin—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.00195	0.0371	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00175	0.0332	CcSEcCtD
Hydroxocobalamin—MMAB—medulla oblongata—amyotrophic lateral sclerosis	0.00173	0.0341	CbGeAlD
Hydroxocobalamin—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00166	0.0314	CcSEcCtD
Hydroxocobalamin—AMN—cerebellum—amyotrophic lateral sclerosis	0.00163	0.0323	CbGeAlD
Hydroxocobalamin—MMACHC—brain—amyotrophic lateral sclerosis	0.00161	0.0319	CbGeAlD
Hydroxocobalamin—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00159	0.0301	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00157	0.0299	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00143	0.0272	CcSEcCtD
Hydroxocobalamin—MMAA—nervous system—amyotrophic lateral sclerosis	0.00138	0.0273	CbGeAlD
Hydroxocobalamin—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00136	0.0257	CcSEcCtD
Hydroxocobalamin—MMAA—central nervous system—amyotrophic lateral sclerosis	0.00133	0.0263	CbGeAlD
Hydroxocobalamin—AMN—brain—amyotrophic lateral sclerosis	0.00133	0.0262	CbGeAlD
Hydroxocobalamin—MMAA—cerebellum—amyotrophic lateral sclerosis	0.0013	0.0257	CbGeAlD
Hydroxocobalamin—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.0013	0.0246	CcSEcCtD
Hydroxocobalamin—MMAB—nervous system—amyotrophic lateral sclerosis	0.0013	0.0256	CbGeAlD
Hydroxocobalamin—MMAB—central nervous system—amyotrophic lateral sclerosis	0.00125	0.0247	CbGeAlD
Hydroxocobalamin—MUT—medulla oblongata—amyotrophic lateral sclerosis	0.00124	0.0245	CbGeAlD
Hydroxocobalamin—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00123	0.0234	CcSEcCtD
Hydroxocobalamin—MMAB—cerebellum—amyotrophic lateral sclerosis	0.00122	0.0241	CbGeAlD
Hydroxocobalamin—CASP9—nervous system—amyotrophic lateral sclerosis	0.00121	0.0239	CbGeAlD
Hydroxocobalamin—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00118	0.0224	CcSEcCtD
Hydroxocobalamin—TCN2—nervous system—amyotrophic lateral sclerosis	0.00118	0.0234	CbGeAlD
Hydroxocobalamin—CASP9—central nervous system—amyotrophic lateral sclerosis	0.00117	0.023	CbGeAlD
Hydroxocobalamin—CASP9—cerebellum—amyotrophic lateral sclerosis	0.00114	0.0225	CbGeAlD
Hydroxocobalamin—TCN2—central nervous system—amyotrophic lateral sclerosis	0.00114	0.0225	CbGeAlD
Hydroxocobalamin—MTRR—medulla oblongata—amyotrophic lateral sclerosis	0.00111	0.022	CbGeAlD
Hydroxocobalamin—MUT—spinal cord—amyotrophic lateral sclerosis	0.0011	0.0218	CbGeAlD
Hydroxocobalamin—MMAA—brain—amyotrophic lateral sclerosis	0.00106	0.0209	CbGeAlD
Hydroxocobalamin—MTRR—spinal cord—amyotrophic lateral sclerosis	0.000992	0.0196	CbGeAlD
Hydroxocobalamin—MMAB—brain—amyotrophic lateral sclerosis	0.000991	0.0196	CbGeAlD
Hydroxocobalamin—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.000975	0.0185	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.000973	0.0185	CcSEcCtD
Hydroxocobalamin—MTR—medulla oblongata—amyotrophic lateral sclerosis	0.00097	0.0192	CbGeAlD
Hydroxocobalamin—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.000968	0.0184	CcSEcCtD
Hydroxocobalamin—MUT—nervous system—amyotrophic lateral sclerosis	0.00093	0.0184	CbGeAlD
Hydroxocobalamin—CASP9—brain—amyotrophic lateral sclerosis	0.000926	0.0183	CbGeAlD
Hydroxocobalamin—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.000923	0.0175	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.000916	0.0174	CcSEcCtD
Hydroxocobalamin—TCN2—brain—amyotrophic lateral sclerosis	0.000904	0.0179	CbGeAlD
Hydroxocobalamin—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.000896	0.017	CcSEcCtD
Hydroxocobalamin—MUT—central nervous system—amyotrophic lateral sclerosis	0.000895	0.0177	CbGeAlD
Hydroxocobalamin—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.000892	0.0169	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00089	0.0169	CcSEcCtD
Hydroxocobalamin—Chills—Riluzole—amyotrophic lateral sclerosis	0.000886	0.0168	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.000882	0.0167	CcSEcCtD
Hydroxocobalamin—MUT—cerebellum—amyotrophic lateral sclerosis	0.000875	0.0173	CbGeAlD
Hydroxocobalamin—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.000865	0.0164	CcSEcCtD
Hydroxocobalamin—MTR—spinal cord—amyotrophic lateral sclerosis	0.000865	0.0171	CbGeAlD
Hydroxocobalamin—MTRR—nervous system—amyotrophic lateral sclerosis	0.000836	0.0165	CbGeAlD
Hydroxocobalamin—MTRR—central nervous system—amyotrophic lateral sclerosis	0.000805	0.0159	CbGeAlD
Hydroxocobalamin—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000798	0.0151	CcSEcCtD
Hydroxocobalamin—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00079	0.015	CcSEcCtD
Hydroxocobalamin—MTRR—cerebellum—amyotrophic lateral sclerosis	0.000786	0.0155	CbGeAlD
Hydroxocobalamin—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.000785	0.0149	CcSEcCtD
Hydroxocobalamin—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000775	0.0147	CcSEcCtD
Hydroxocobalamin—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000732	0.0139	CcSEcCtD
Hydroxocobalamin—MTR—nervous system—amyotrophic lateral sclerosis	0.000729	0.0144	CbGeAlD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000727	0.0138	CcSEcCtD
Hydroxocobalamin—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000723	0.0137	CcSEcCtD
Hydroxocobalamin—MUT—brain—amyotrophic lateral sclerosis	0.000711	0.014	CbGeAlD
Hydroxocobalamin—MTR—central nervous system—amyotrophic lateral sclerosis	0.000702	0.0139	CbGeAlD
Hydroxocobalamin—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000702	0.0133	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000702	0.0133	CcSEcCtD
Hydroxocobalamin—Infection—Riluzole—amyotrophic lateral sclerosis	0.000697	0.0132	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000688	0.0131	CcSEcCtD
Hydroxocobalamin—MTR—cerebellum—amyotrophic lateral sclerosis	0.000686	0.0136	CbGeAlD
Hydroxocobalamin—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000685	0.013	CcSEcCtD
Hydroxocobalamin—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000681	0.0129	CcSEcCtD
Hydroxocobalamin—MTRR—brain—amyotrophic lateral sclerosis	0.000639	0.0126	CbGeAlD
Hydroxocobalamin—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000625	0.0119	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000618	0.0117	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000606	0.0115	CcSEcCtD
Hydroxocobalamin—Pain—Riluzole—amyotrophic lateral sclerosis	0.0006	0.0114	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000578	0.011	CcSEcCtD
Hydroxocobalamin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000557	0.0106	CcSEcCtD
Hydroxocobalamin—MTR—brain—amyotrophic lateral sclerosis	0.000557	0.011	CbGeAlD
Hydroxocobalamin—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000555	0.0105	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000517	0.0098	CcSEcCtD
Hydroxocobalamin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000496	0.00942	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00048	0.00911	CcSEcCtD
Hydroxocobalamin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000464	0.0088	CcSEcCtD
Hydroxocobalamin—Rash—Riluzole—amyotrophic lateral sclerosis	0.000442	0.00839	CcSEcCtD
Hydroxocobalamin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000442	0.00838	CcSEcCtD
Hydroxocobalamin—Headache—Riluzole—amyotrophic lateral sclerosis	0.000439	0.00834	CcSEcCtD
Hydroxocobalamin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000417	0.0079	CcSEcCtD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—ERBB4—amyotrophic lateral sclerosis	0.000136	0.00115	CbGpPWpGaD
Hydroxocobalamin—MTRR—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.000134	0.00114	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB4—ERBB4—amyotrophic lateral sclerosis	0.000133	0.00114	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PLB1—amyotrophic lateral sclerosis	0.000133	0.00114	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000131	0.00112	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000131	0.00112	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—GSR—amyotrophic lateral sclerosis	0.00013	0.00111	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—GSR—amyotrophic lateral sclerosis	0.00013	0.00111	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—ATF1—amyotrophic lateral sclerosis	0.000128	0.00109	CbGpPWpGaD
Hydroxocobalamin—CASP9—AGE/RAGE pathway—CASP3—amyotrophic lateral sclerosis	0.000128	0.00109	CbGpPWpGaD
Hydroxocobalamin—CASP9—Amyotrophic lateral sclerosis (ALS)—TP53—amyotrophic lateral sclerosis	0.000128	0.00109	CbGpPWpGaD
Hydroxocobalamin—CASP9—Intrinsic Pathway for Apoptosis—TP53—amyotrophic lateral sclerosis	0.000128	0.00109	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—ERBB4—amyotrophic lateral sclerosis	0.000127	0.00109	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—ERBB4—amyotrophic lateral sclerosis	0.000127	0.00108	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—ERBB4—amyotrophic lateral sclerosis	0.000126	0.00107	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000126	0.00107	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000126	0.00107	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—ERBB4—amyotrophic lateral sclerosis	0.000126	0.00107	CbGpPWpGaD
Hydroxocobalamin—CASP9—DNA Damage Response—CASP3—amyotrophic lateral sclerosis	0.000125	0.00106	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—VCP—amyotrophic lateral sclerosis	0.000124	0.00106	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—VCP—amyotrophic lateral sclerosis	0.000124	0.00106	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—ERBB4—amyotrophic lateral sclerosis	0.000124	0.00105	CbGpPWpGaD
Hydroxocobalamin—CASP9—p75(NTR)-mediated signaling—CASP3—amyotrophic lateral sclerosis	0.000123	0.00105	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000123	0.00105	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PLB1—amyotrophic lateral sclerosis	0.000123	0.00105	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—BDNF—amyotrophic lateral sclerosis	0.000121	0.00103	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000121	0.00103	CbGpPWpGaD
Hydroxocobalamin—CASP9—AGE/RAGE pathway—MMP9—amyotrophic lateral sclerosis	0.000121	0.00103	CbGpPWpGaD
Hydroxocobalamin—CASP9—miRNA Regulation of DNA Damage Response—CASP3—amyotrophic lateral sclerosis	0.000121	0.00103	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—VTA1—amyotrophic lateral sclerosis	0.00012	0.00102	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—VCP—amyotrophic lateral sclerosis	0.000119	0.00101	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—ERBB4—amyotrophic lateral sclerosis	0.000118	0.00101	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—ERBB4—amyotrophic lateral sclerosis	0.000118	0.00101	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—ERBB4—amyotrophic lateral sclerosis	0.000118	0.00101	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—CST3—amyotrophic lateral sclerosis	0.000118	0.001	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—ERBB4—amyotrophic lateral sclerosis	0.000117	0.000997	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000117	0.000997	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000117	0.000997	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000117	0.000997	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—ERBB4—amyotrophic lateral sclerosis	0.000116	0.000988	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—ERBB4—amyotrophic lateral sclerosis	0.000115	0.000984	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000115	0.000981	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000113	0.000967	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TPK1—amyotrophic lateral sclerosis	0.000113	0.000964	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000112	0.000951	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—DAO—amyotrophic lateral sclerosis	0.000112	0.000951	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000112	0.000951	CbGpPWpGaD
Hydroxocobalamin—CASP9—Alzheimers Disease—CASP3—amyotrophic lateral sclerosis	0.000111	0.000944	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	0.000111	0.000944	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—VCP—amyotrophic lateral sclerosis	0.00011	0.000934	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000109	0.000932	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—ERBB4—amyotrophic lateral sclerosis	0.000109	0.000931	CbGpPWpGaD
Hydroxocobalamin—MTR—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.000109	0.000928	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—GSR—amyotrophic lateral sclerosis	0.000108	0.00092	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—GSR—amyotrophic lateral sclerosis	0.000108	0.00092	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—CST3—amyotrophic lateral sclerosis	0.000108	0.000919	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—CST3—amyotrophic lateral sclerosis	0.000108	0.000919	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000107	0.000912	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000107	0.000912	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000107	0.000912	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—CASP3—amyotrophic lateral sclerosis	0.000105	0.000899	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—SQSTM1—amyotrophic lateral sclerosis	0.000105	0.000897	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—ERBB4—amyotrophic lateral sclerosis	0.000105	0.000891	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000104	0.00089	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000103	0.000877	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—GSR—amyotrophic lateral sclerosis	0.000103	0.000877	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PLB1—amyotrophic lateral sclerosis	0.000101	0.00086	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000101	0.000857	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—CST3—amyotrophic lateral sclerosis	0.0001	0.000854	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—CHAT—amyotrophic lateral sclerosis	9.95e-05	0.000847	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis Modulation and Signaling—CASP3—amyotrophic lateral sclerosis	9.89e-05	0.000843	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—ATF1—amyotrophic lateral sclerosis	9.87e-05	0.000841	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.83e-05	0.000838	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.83e-05	0.000838	CbGpPWpGaD
Hydroxocobalamin—CASP9—Corticotropin-releasing hormone—CASP3—amyotrophic lateral sclerosis	9.81e-05	0.000836	CbGpPWpGaD
Hydroxocobalamin—CASP9—TNF alpha Signaling Pathway—CASP3—amyotrophic lateral sclerosis	9.81e-05	0.000836	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—GSR—amyotrophic lateral sclerosis	9.5e-05	0.00081	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	9.4e-05	0.000801	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.38e-05	0.000799	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—KIFAP3—amyotrophic lateral sclerosis	9.28e-05	0.000791	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CHMP2B—amyotrophic lateral sclerosis	9.1e-05	0.000776	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—DAO—amyotrophic lateral sclerosis	9.1e-05	0.000775	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—VTA1—amyotrophic lateral sclerosis	9.04e-05	0.00077	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—DCTN1—amyotrophic lateral sclerosis	9.02e-05	0.000769	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—VCP—amyotrophic lateral sclerosis	9e-05	0.000767	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—CST3—amyotrophic lateral sclerosis	8.93e-05	0.000761	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—CST3—amyotrophic lateral sclerosis	8.93e-05	0.000761	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—CHAT—amyotrophic lateral sclerosis	8.86e-05	0.000755	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—CHAT—amyotrophic lateral sclerosis	8.86e-05	0.000755	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	8.65e-05	0.000737	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—CASP9—amyotrophic lateral sclerosis	8.57e-05	0.00073	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—CST3—amyotrophic lateral sclerosis	8.52e-05	0.000726	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—CHAT—amyotrophic lateral sclerosis	8.46e-05	0.000721	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PLB1—amyotrophic lateral sclerosis	8.46e-05	0.000721	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PLB1—amyotrophic lateral sclerosis	8.23e-05	0.000701	CbGpPWpGaD
Hydroxocobalamin—CASP9—Rac1/Pak1/p38/MMP-2 pathway—TP53—amyotrophic lateral sclerosis	8.1e-05	0.00069	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.09e-05	0.000689	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.09e-05	0.000689	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—ERBB4—amyotrophic lateral sclerosis	8.04e-05	0.000685	CbGpPWpGaD
Hydroxocobalamin—CASP9—DNA Damage Response—TP53—amyotrophic lateral sclerosis	8.01e-05	0.000682	CbGpPWpGaD
Hydroxocobalamin—CASP9—p75(NTR)-mediated signaling—TP53—amyotrophic lateral sclerosis	7.91e-05	0.000674	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—CST3—amyotrophic lateral sclerosis	7.87e-05	0.00067	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—CASP9—amyotrophic lateral sclerosis	7.84e-05	0.000668	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—CASP9—amyotrophic lateral sclerosis	7.84e-05	0.000668	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—CHAT—amyotrophic lateral sclerosis	7.8e-05	0.000665	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—GSR—amyotrophic lateral sclerosis	7.8e-05	0.000665	CbGpPWpGaD
Hydroxocobalamin—CASP9—miRNA Regulation of DNA Damage Response—TP53—amyotrophic lateral sclerosis	7.74e-05	0.000659	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.72e-05	0.000657	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—ERBB4—amyotrophic lateral sclerosis	7.34e-05	0.000625	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—VCP—amyotrophic lateral sclerosis	7.34e-05	0.000625	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—CASP9—amyotrophic lateral sclerosis	7.29e-05	0.000621	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.12e-05	0.000607	CbGpPWpGaD
Hydroxocobalamin—CASP9—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	7.1e-05	0.000605	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	7.1e-05	0.000605	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PLB1—amyotrophic lateral sclerosis	6.89e-05	0.000587	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CHMP2B—amyotrophic lateral sclerosis	6.85e-05	0.000584	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—TP53—amyotrophic lateral sclerosis	6.76e-05	0.000576	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—ERBB4—amyotrophic lateral sclerosis	6.71e-05	0.000572	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—ERBB4—amyotrophic lateral sclerosis	6.71e-05	0.000572	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	6.6e-05	0.000562	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—MMP9—amyotrophic lateral sclerosis	6.59e-05	0.000561	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—CASP9—amyotrophic lateral sclerosis	6.5e-05	0.000554	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—CASP9—amyotrophic lateral sclerosis	6.5e-05	0.000554	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—CASP3—amyotrophic lateral sclerosis	6.46e-05	0.000551	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CST3—amyotrophic lateral sclerosis	6.46e-05	0.00055	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—CHAT—amyotrophic lateral sclerosis	6.41e-05	0.000546	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—GSR—amyotrophic lateral sclerosis	6.36e-05	0.000542	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis Modulation and Signaling—TP53—amyotrophic lateral sclerosis	6.34e-05	0.00054	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.29e-05	0.000536	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—ERBB4—amyotrophic lateral sclerosis	6.24e-05	0.000532	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PLB1—amyotrophic lateral sclerosis	6.2e-05	0.000528	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—CASP9—amyotrophic lateral sclerosis	6.2e-05	0.000528	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—CASP3—amyotrophic lateral sclerosis	6.06e-05	0.000516	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	5.89e-05	0.000502	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.78e-05	0.000492	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.75e-05	0.00049	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.75e-05	0.00049	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—CASP9—amyotrophic lateral sclerosis	5.72e-05	0.000487	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—APOE—amyotrophic lateral sclerosis	5.68e-05	0.000484	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—ATF1—amyotrophic lateral sclerosis	5.63e-05	0.00048	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	5.6e-05	0.000477	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—ERBB4—amyotrophic lateral sclerosis	5.56e-05	0.000474	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—ERBB4—amyotrophic lateral sclerosis	5.56e-05	0.000474	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.54e-05	0.000472	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.54e-05	0.000472	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—VCP—amyotrophic lateral sclerosis	5.52e-05	0.000471	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—DCTN1—amyotrophic lateral sclerosis	5.47e-05	0.000466	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	5.47e-05	0.000466	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.35e-05	0.000455	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—ERBB4—amyotrophic lateral sclerosis	5.3e-05	0.000452	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.29e-05	0.000451	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.28e-05	0.00045	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.28e-05	0.00045	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CST3—amyotrophic lateral sclerosis	5.27e-05	0.000449	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—CHAT—amyotrophic lateral sclerosis	5.22e-05	0.000445	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—APOE—amyotrophic lateral sclerosis	5.19e-05	0.000442	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—APOE—amyotrophic lateral sclerosis	5.19e-05	0.000442	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.91e-05	0.000419	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—ERBB4—amyotrophic lateral sclerosis	4.9e-05	0.000417	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.88e-05	0.000416	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—APOE—amyotrophic lateral sclerosis	4.83e-05	0.000411	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.76e-05	0.000406	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.76e-05	0.000406	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—APOE—amyotrophic lateral sclerosis	4.75e-05	0.000405	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CASP9—amyotrophic lateral sclerosis	4.7e-05	0.0004	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	4.64e-05	0.000395	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	4.59e-05	0.000391	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.54e-05	0.000387	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	4.41e-05	0.000375	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.38e-05	0.000373	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.38e-05	0.000373	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—APOE—amyotrophic lateral sclerosis	4.35e-05	0.00037	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—APOE—amyotrophic lateral sclerosis	4.35e-05	0.00037	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	4.34e-05	0.00037	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—APOE—amyotrophic lateral sclerosis	4.3e-05	0.000367	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—APOE—amyotrophic lateral sclerosis	4.3e-05	0.000367	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	4.23e-05	0.00036	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.19e-05	0.000357	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.18e-05	0.000356	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—TP53—amyotrophic lateral sclerosis	4.14e-05	0.000353	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	4.14e-05	0.000353	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—APOE—amyotrophic lateral sclerosis	4.1e-05	0.00035	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	4.08e-05	0.000348	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—APOE—amyotrophic lateral sclerosis	4.04e-05	0.000344	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—ERBB4—amyotrophic lateral sclerosis	4.02e-05	0.000343	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CST3—amyotrophic lateral sclerosis	3.96e-05	0.000338	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	3.96e-05	0.000337	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—PTGS2—amyotrophic lateral sclerosis	3.89e-05	0.000331	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—TP53—amyotrophic lateral sclerosis	3.88e-05	0.000331	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—VCP—amyotrophic lateral sclerosis	3.87e-05	0.00033	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.85e-05	0.000328	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CASP9—amyotrophic lateral sclerosis	3.83e-05	0.000326	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—C3—amyotrophic lateral sclerosis	3.81e-05	0.000325	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—APOE—amyotrophic lateral sclerosis	3.79e-05	0.000323	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	3.75e-05	0.000319	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—C3—amyotrophic lateral sclerosis	3.66e-05	0.000312	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—APOE—amyotrophic lateral sclerosis	3.6e-05	0.000307	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—APOE—amyotrophic lateral sclerosis	3.6e-05	0.000307	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—PTGS2—amyotrophic lateral sclerosis	3.56e-05	0.000303	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—PTGS2—amyotrophic lateral sclerosis	3.56e-05	0.000303	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	3.5e-05	0.000299	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—SQSTM1—amyotrophic lateral sclerosis	3.5e-05	0.000298	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.44e-05	0.000294	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—APOE—amyotrophic lateral sclerosis	3.44e-05	0.000293	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	3.33e-05	0.000283	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—PTGS2—amyotrophic lateral sclerosis	3.31e-05	0.000282	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	3.29e-05	0.00028	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—ATF1—amyotrophic lateral sclerosis	3.28e-05	0.000279	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—ERBB4—amyotrophic lateral sclerosis	3.28e-05	0.000279	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.26e-05	0.000278	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—APOE—amyotrophic lateral sclerosis	3.17e-05	0.00027	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.17e-05	0.00027	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—APOE—amyotrophic lateral sclerosis	3.11e-05	0.000265	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.98e-05	0.000254	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.98e-05	0.000254	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—PTGS2—amyotrophic lateral sclerosis	2.95e-05	0.000251	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PTGS2—amyotrophic lateral sclerosis	2.95e-05	0.000251	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PTGS2—amyotrophic lateral sclerosis	2.81e-05	0.00024	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.81e-05	0.000239	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.77e-05	0.000236	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—ERBB4—amyotrophic lateral sclerosis	2.67e-05	0.000228	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—APOE—amyotrophic lateral sclerosis	2.6e-05	0.000222	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PTGS2—amyotrophic lateral sclerosis	2.59e-05	0.000221	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.58e-05	0.00022	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—APOE—amyotrophic lateral sclerosis	2.53e-05	0.000216	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD40LG—amyotrophic lateral sclerosis	2.51e-05	0.000214	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.47e-05	0.00021	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.47e-05	0.00021	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—ERBB4—amyotrophic lateral sclerosis	2.47e-05	0.00021	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.35e-05	0.000201	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.26e-05	0.000193	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—C3—amyotrophic lateral sclerosis	2.22e-05	0.000189	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.17e-05	0.000185	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PTGS2—amyotrophic lateral sclerosis	2.13e-05	0.000182	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—APOE—amyotrophic lateral sclerosis	2.12e-05	0.000181	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.12e-05	0.000181	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—APOE—amyotrophic lateral sclerosis	1.91e-05	0.000163	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.78e-05	0.000152	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTGS2—amyotrophic lateral sclerosis	1.74e-05	0.000148	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.73e-05	0.000147	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.62e-05	0.000138	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.45e-05	0.000124	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.44e-05	0.000122	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.34e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTGS2—amyotrophic lateral sclerosis	1.31e-05	0.000111	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.1e-05	9.41e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.5e-06	7.24e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.03e-06	6.85e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.21e-06	6.15e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.45e-06	4.64e-05	CbGpPWpGaD
